#Canada #AHS #ChemDAQ #St. John's, Newfoundland and Labrador #Chemical Monitoring

Introduction

ChemDAQ has recently announced a significant partnership with Associated Health Systems Inc. (AHS), aiming to enhance the safety and efficiency of chemical monitoring in healthcare settings across Canada. This collaboration marries ChemDAQ's advanced hazardous gas monitoring technology with AHS’s extensive experience in providing healthcare organizations with essential tools and products.

The Significance of the Partnership

Founded over 35 years ago, AHS has a long-standing reputation in the healthcare sector as a reliable distributor and manufacturer of medical devices and equipment. Their commitment to improving patient care and operational efficiencies aligns perfectly with ChemDAQ’s mission to create safer work environments. With their new partnership, both companies seek to deliver essential monitoring solutions that ensure the safety of both staff and patients.

Continuous Monitoring Technology

ChemDAQ specializes in offering continuous monitoring solutions for hazardous chemical vapors, particularly in environments where sterilization is critical. The collaboration will enable medical device reprocessing (MDR) departments across Canada to access ChemDAQ’s cutting-edge sensors, including those for hydrogen peroxide (H2O2), peracetic acid (PAA), and ethylene oxide (EtO). By implementing these technologies, healthcare providers will gain real-time insights into their work environments, thereby reducing risks linked with chemical exposure.

Commitment to Safety

In healthcare, the risks associated with chemical exposure can be especially concerning. Alex Hilliker, Executive Vice President of ChemDAQ, emphasized that the safety of healthcare workers should be held to the same standard as patient safety. This new partnership aims to arm Canadian hospitals with effective monitoring solutions that will empower teams to understand their work environments better and minimize chemical exposure hazards.

The Upcoming CAMDR Conference

The partnership will be officially introduced at the Canadian Association of Medical Device Reprocessing (CAMDR) 2026 conference, set to take place from October 22nd to 24th in St. John's, Newfoundland and Labrador. ChemDAQ and AHS will have a joint presence at the event, bringing their innovative solutions directly to medical professionals in the reprocessing community.

Engaging Discussions

During the conference, representatives from both organizations will lead a presentation titled, "Are You Safe? How Do You Know? Chemical Exposure in MDR". This session is poised to delve into various important aspects, including the risks linked with chemical vapor exposure from sterilants and disinfectants, and strategies for better exposure management in work environments.

Conclusion

The partnership between ChemDAQ and AHS symbolizes a proactive step towards advancing safety standards within Canadian healthcare systems. Through their joint efforts, these companies aspire to not only enhance the safety of healthcare workers but to set a precedent for the significance of monitoring technologies in safeguarding public health. For further insights into their offerings and to stay updated, healthcare providers can visit the respective websites of ChemDAQ and AHS.

For more information, visit ChemDAQ and AHS.